Abstract
Depolarization-induced suppression of excitation (DSE) is a major form of cannabinoid-mediated short-term retrograde neuronal plasticity and is found in numerous brain regions. Autaptically cultured murine hippocampal neurons are an architecturally simple model for the study of cannabinoid signaling, including DSE. The transient nature of DSE—tens of seconds—is probably determined by the regulated hydrolysis of the endocannabinoid 2-arachidonoyl glycerol (2-AG). No less than five candidate enzymes have been considered to serve this role: fatty acid amide hydrolase (FAAH), cyclooxygenase-2 (COX-2), monoacylglycerol lipase (MGL), and α/β-hydrolase domain (ABHD) 6 and 12. We previously found that FAAH and COX-2 do not have a role in determining the duration of autaptic DSE. In the current study, we found that two structurally distinct inhibitors of MGL [N-arachidonoyl maleimide and 4-nitrophenyl 4-(dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate (JZL184)] prolong DSE in autaptic hippocampal neurons, whereas inhibition of ABHD6 by N-methyl-N-[[3-(4-pyridinyl)phenyl]methyl]-4′-(aminocarbonyl)[1,1′-biphenyl]-4-yl ester, carbamic acid (WWL70) had no effect. In addition, we developed antibodies against MGL and ABHD6 and determined their expression in autaptic cultures. MGL is chiefly expressed at presynaptic terminals, optimally positioned to break down 2-AG that has engaged presynaptic CB1 receptors. ABHD6 is expressed in two distinct locations on autaptic islands, including a prominent localization in some dendrites. In summary, we provide strong pharmacological and anatomical evidence that MGL regulates DSE in autaptic hippocampal neurons and, taken together with other studies, emphasizes that endocannabinoid signaling is terminated in temporally diverse ways.
Footnotes
This work was supported by the National Institutes of Health National Institute on Drug Abuse [Grants DA11322, DA021696, DA024122]; the Lilly Endowment, Inc.; and the Indiana University Light Microscopy Imaging Center.
Article, publication date, and citation information can be found at http://molpharm.aspetjournals.org.
doi:10.1124/mol.109.059030
-
ABBREVIATIONS:
- eCB
- endocannabinoid
- DSE
- depolarization-induced suppression of excitation
- DSI
- depolarization-induced suppression of inhibition
- 2-AG
- 2-arachidonoyl glycerol
- DAG
- diacylglycerol
- FAAH
- fatty acid amide hydrolase
- COX-2
- cyclooxygenase 2
- MGL
- monoacylglycerol lipase
- DSI
- depolarization-induced suppression of inhibition
- URB754
- 6-methyl-2-[(4-methylphenyl)amino]-1-benzoxazin-4-one
- URB602
- [1,1′-biphenyl]-3-yl-carbamic acid, cyclohexyl ester
- EPSC
- excitatory postsynaptic current
- HEK
- human embryonic kidney
- GST
- glutathione transferase
- mMGL
- mouse MGL
- mABHD6
- mouse ABHD6
- HA
- hemagglutinin
- rMGL
- rat MGL
- PB
- phosphate buffer
- PBS
- phosphate-buffered saline
- FITC
- fluorescein isothiocyanate
- DAPI
- 4,6-diamidino-2-phenylindole
- NAM
- N-arachidonoyl maleimide
- JZL184
- 4-nitrophenyl 4-(dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate
- WWL70
- N-methyl-N-[[3-(4-pyridinyl)phenyl]methyl]-4′-(aminocarbonyl)[1,1′-biphenyl]-4-yl ester, carbamic acid
- SR141716
- N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboximide hydrochloride
- WIN55212-2
- (R)-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinylmethyl) pyrrolo-[1,2,3-d,e]-1,4-benzoxazin-6-yl]-1-naphthalenyl-methanone;
- WIN
- WIN55212-2
- SV2
- synaptic vesicle protein 2
- MAP2
- microtubule-associated protein 2.
- Received July 6, 2009.
- Accepted September 18, 2009.
- © 2009 The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|